Derlend Biotech
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- Undisclosed
Investors
- 4
About Derlend Biotech
Established in 2012 and based in Hangzhou, China, Derlend Biotech is a medical device's company specializing in the independent development, production, sales, and service of in vitro diagnostic reagent products. The company owns 3 invention patents and has obtained 3 registration certificates for fungal nucleic acid detection kits for Class III IVD products from the State Drug Administration. The company's main business is the research and development, production and sales of in vitro diagnostic reagent products. The company's mainly products include fungal nucleic acid detection kit series, fungal nucleic acid extraction and purification kit series, fungal immunofluorescence staining solution series and other in vitro diagnostic reagent products.
Who invested in Derlend Biotech
4 investors across 2 rounds
See all investors in Derlend Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Derlend Biotech
Who invested in Derlend Biotech?
Derlend Biotech has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Derlend Biotech raised?
Derlend Biotech has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Derlend Biotech last raise money?
Derlend Biotech's most recent round on record is a Series A, in Jul 2023.
What does Derlend Biotech do?
Established in 2012 and based in Hangzhou, China, Derlend Biotech is a medical device's company specializing in the independent development, production, sales, and service of in vitro diagnostic reagent products.
Where is Derlend Biotech headquartered?
Derlend Biotech is headquartered in Hangzhou, China.
Which VCs invest in companies like Derlend Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Derlend Biotech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Derlend Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.